This live training webinar will discuss the just issued (July 2015) DRAFT Guidance for Industry on “Request for Quality Metrics” along with how FDASIA is pushing it forward, review the most common Citations issued during the past several years, dissect each resultant Observation, explain the rationale behind them and present actual examples of Form FDA 483s and Warning Letters that include that particular Observation. A total of approximately 15 sections within CDER’s CFRs from each year will be examined in detail and their frequency compared against previous years. This webinar is especially valuable to not only those within the Quality area of your Company, but also within other Departments to include Incoming Raw Materials, Manufacturing and Facilities. Because of the sensitivity and importance of understanding Quality Metrics, this live training webinar is a MUST for anyone in your organization that is involved in the management of, or recipients of Regulatory actions.
Course Objectives:
• Learn about the new proposed “Request for Quality Metrics” and its Relationship to FDASIA
• Understand the Requirements of the FDA’s Request to Industry
• Determine how the Draft Relates to Most Frequent Citations from 21 CFR 210/211
• Learn of the Most Frequent Citations from within the 21 CFR 210/211 (Code of Federal Regulations (CFR)
• Review of the Past Several Years’ Overall Major Citations and how They may Impact your Organization
• Hear the Rationale Behind an Observation and why the Underlying “Citation” was Cited
• Comparison of Citations against Observations within Warning Letters
• Interpretation of the Results
• Review of Pertinent Form FDA 483s and Warning Letters
Course Outline:
• Introduction
• Human Drug Establishment Inclusion & Expectations
• Quality Metrics Background
• Process Validation and Quality Metrics
• The Use of Quality Metrics
• Effects of Non-Reporting
• Reporting of Quality Metrics
• Review of Pertinent Form FDA 483s and Warning Letters
• Summary
What You Get:
• Training Materials
• Live Q&A Session with our Expert
• Participation Certificate
• Access to Signup Community (Optional)
• Reward Points
Who Will Benefit:
• Quality Assurance personnel
• Quality Control personnel
• Research & Development
• Manufacturing
• Regulatory Affairs Professionals
• Facilities
• Those that use contract manufacturing and contract testing facilities
• Contract Laboratories
• API Manufacturers
• Medical Device Companies
Two New FDA Draft Guidance Documents: Medical Devices and 510k Submission
Get Instant Access 90 Minutes View Program |
How to Prepare for and Host a FDA Inspection and Avoid 483’s (based on practical experience)
Get Instant Access 60 Minutes View Program |
How the FDA are Trained for Medical Device Inspections
Get Instant Access 90 Minutes View Program |
Raw Materials Risk Management In GMP Facilities: Avoiding GMP Non-Compliance Due to Raw Material Issues
Get Instant Access 90 Minutes View Program |
ISO 13485: 2016 - Understanding and Implementing The International Medical Device Quality Standard
Get Instant Access 90 Minutes View Program |
Get Instant Access On-Demand Access
Preparing for the ICE Storm: What to Do During I 9 Audits and ICE Raids
Janette S. Levey
Human Resources
Get Instant Access On-Demand Access
OSHA Inspections and Investigations-How to Manage Them
Irwin Dobrushin
Environment Health and Safety | OSHA
Get Instant Access On-Demand Access
29 CFR 1904: OSHA's New Injury Recordkeeping E-Submission Rule
Occupational Safety and Health Administration
Get Instant Access On-Demand Access
Working with Excel Databases: Sort, Filter, Subtotal and More
Cathy Horwitz
Cross Industry | Skill Enhancement
Get Instant Access On-Demand Access
Writing Audit Reports
Jonnie T. Keith CIA, CFE, CGAP, CICA
Governance, Risk and Compliance
Get Instant Access On-Demand Access
BSA Reporting Requirements
Banking and Financial Services Industry
Get Instant Access On-Demand Access
Human Factors-Usability Based on ISO 62366
Medical Device | Diagnostic | Pharmaceutical | Biologics fields
Get Instant Access On-Demand Access
Chat GPT for Project Managers
Charles H. Paul
All FDA Regulated Industry